Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers
Authors:
Open Access
- 19 July 2023
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 94, 104706
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81971631, 91959127)
- Natural Science Foundation of Guangdong Province (2023A1515011564)
This publication has 30 references indexed in Scilit:
- Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancerBreast Cancer Research and Treatment, 2016
- Bevacizumab in neoadjuvant chemotherapy increases the pathological complete response rate in patients with triple‐negative breast cancerCA: A Cancer Journal for Clinicians, 2014
- Luminal breast cancer: from biology to treatmentNature Reviews Clinical Oncology, 2013
- Assessing the Role of Ultrasound in Predicting the Biological Behavior of Breast CancerAmerican Journal of Roentgenology, 2013
- Does Breast Tumor Heterogeneity Necessitate Further Immunohistochemical Staining on Surgical Specimens?Journal of the American College of Surgeons, 2013
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trialThe Lancet Oncology, 2012
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Journal of Clinical Oncology, 2008
- Re-evaluating Adjuvant Breast Cancer Trials: Assessing Hormone Receptor Status by Immunohistochemical Versus Extraction AssaysJNCI: Journal of the National Cancer Institute, 2006
- The basic biology of HER2Annals of Oncology, 2001